Cure TV

Kevin B. Kim, of the California Pacific Medical Center, explains how patients with melanoma who are in remission can get back into a normal, daily routine while still taking precautions.

At age 22, Megan Miller was diagnosed with basal cell carcinoma, a common form of skin cancer that can be easily treated. But a year later, she was diagnosed with melanoma.

Deanna J. Attai, breast surgeon and assistant clinical professor of surgery at the David Geffen School of Medicine, University of California, in Los Angeles, shares ways social media can help cancer patients and survivors.

In a recent study, researchers looked at statins and survival outcomes, along with potential side effects, in patients with metastatic renal cell carcinoma.

In 1995, Sam Donaldson, ABC news veteran, found a lump that ultimately led to a diagnosis of melanoma.

Hyman B. Muss, professor of oncology at the University of North Carolina and director of geriatric oncology at the Lineberger Comprehensive Cancer Center, discusses how patients with breast cancer should press their physicians to help them make the best medical decisions.

Naomi Haas, of the Abramson Cancer Center, explains the potential side effects of a class of drugs called mTOR inhibitors, primarily the agents Sutent and Nexavar.

Leonard Gomella, chair of the urology department and director of the Kimmel Cancer Center Network, explains active surveillance when it comes to a prostate cancer diagnosis.

Adam Asch, senior deputy director of Stephenson Cancer Center, gives advice to patients after they have been diagnosed with lymphoma.

Lung cancer specialist Mark Socinski, of the University of Pittsburgh Cancer Institute, discusses how screening for lung cancer has evolved in the past few years, and how it can benefit individuals at high risk for lung cancer.

om Henricks, a former NASA astronaut, shares how the lessons he learned as a pilot and astronaut could be used by someone dealing with cancer.

Smoking cessation is very important for patients diagnosed with cancer, not only because it can negatively impact the outcome of cancer treatment, but it will help to reduce the risk of future cancers.

Howard S. Hochster, an oncologist at Yale Cancer Center who specializes in gastrointestinal cancers, explains when and why individuals should consider colorectal cancer screening.

Jacquelyn Lauria, a nurse at The Cancer Institute of New Jersey, offers tips on how to make lifestyle changes after a cancer diagnosis.

The relationship between a patient and an oncologist needs to be a very open one, says oncologist Heather Wakelee, associate professor of oncology at the Stanford University Medical Center.

Min Li, of the University of Texas Health Sciences Health Science Center in Houston, offers dietary and lifestyle suggestions for newly diagnosed pancreatic cancer patients.

Stuart Goldberg, hematologist/oncologist at John Theurer Cancer Center, discusses some of the common questions he gets from his patients with chronic myeloid leukemia.

When it comes to managing your risk of cancer, especially when dealing with a familial cancer risk, "what is right for one person, may not be right for another," says Amy Byer Shainman.

Debu Tripathy, editor-in-chief of CURE magazine, discusses updates from the Miami Breast Cancer Conference, including the changing landscape of HER2-positive breast cancer.

Debu Tripathy, editor-in-chief of CURE magazine and breast oncologist, discusses genetic testing from the 32nd annual Miami Breast Cancer Conference.

Debu Tripathy, CURE's editor-in-chief, reports on surgical research updates announced at the Miami Breast Cancer Conference held in late February.

The evolution of the treatment for hormone receptor-positive breast cancer was a hot topic for this year's Miami Breast Cancer Conference. Debu Tripathy, CURE's editor-in-chief and breast oncologist, reports from the meeting.

Richard Joseph, assistant professor of medical oncology at Mayo Clinic in Jacksonville, Florida, explains how treatment outcomes for metastatic melanoma have grown in the past few years.

Omid Hamid, chief of clinical research and immunotherapy at The Angeles Clinic and Research Institute, explains how he helps ease his patients' fears after a diagnosis of metastatic melanoma.

Heather Wakelee, of Stanford University Medical Center, discusses the importance of molecular profiling in predicting the response of EGFR inhibitors for patients with non-small cell lung cancer.

Lung cancer specialist Mark Socinski, at the University of Pittsburgh Cancer Institute, discusses VeriStrat testing and how it may be useful in the diagnosis of non-small cell lung cancer.

Immunotherapies have strong potential as a treatment option for patients with NSCLC, as clinical trials have shown dramatic and durable results.

Anees B. Chagpar, director of the Breast Center at Smilow Cancer Hospital at Yale-New Haven Hospital in Connecticut, discusses why certain patients should receive genetic counseling and testing for breast cancer.